Biogen Inc. has entered into a research collaboration with Dayra Therapeutics to discover and develop oral macrocyclic peptides targeting high-priority immunological conditions.
Biotechnology | 26/11/2025 | By Darshana | 137
Harbour BioMed Advances Global Biotherapeutics Collaboration With AstraZeneca
The alliance focuses on discovering and developing next-generation biotherapeutics, including antibody-drug conjugates and T-cell engagers, by combining the scientific strengths of both companies.
Biotechnology | 25/11/2025 | By Darshana | 155
Freudenberg Expands Bioprocessing Capabilities at CPHI and PMEC India
The global manufacturer has introduced its CleanAssure system, a cleanroom-based sanitary washing and drying workstation that uses ultra-purified water and filtered air to enhance safety for single-use tubings and assemblies.
Biotechnology | 25/11/2025 | By Darshana | 144
India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease
India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free nation, with Union Minister of State for Science & Technology Dr. Jitendra Singh launching the country's first indigenous CRISPR-based gene therapy for the condition.
Biotechnology | 20/11/2025 | By Dineshwori | 603
EirGenix Signs Second Global Licensing Deal With Sandoz for Pertuzumab Biosimilar
EirGenix Inc., a Taiwan-based biopharmaceutical and CDMO company, has signed a second global exclusive licensing agreement with Sandoz AG for the commercialization of its pertuzumab biosimilar EG1206A, developed as an alternative to Roche’s Perjeta.
Biotechnology | 14/11/2025 | By Darshana | 242
Dyadic International, Inc. (operating as Dyadic Applied BioSolutions), a US-based biotechnology innovator, has appointed international business development consultancy Intralink to expand its commercial presence in Japan and South Korea — two of Asia’s fastest-growing and most advanced biopharmaceutical markets.
Biotechnology | 10/11/2025 | By Darshana | 225
Bharat Biotech Launches Nucelion, a New CRDMO Focused on Cell and Gene Therapies
The new entity, based in Genome Valley, Hyderabad, is designed to partner with global life-science innovators to deliver end-to-end solutions for complex biologic medicines.
Biotechnology | 03/11/2025 | By Darshana | 445
FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.
Biotechnology | 31/10/2025 | By Darshana | 240
Medinet Japan partners with India's Stempeutics for Stempeucel cell therapy to treat CLTI
Medinet Co., Ltd, a Tokyo-listed regenerative medicine and CDMO company, has signed an option licence agreement with India-based Stempeutics Research for the development and commercialisation of its Stempeucel therapy in Japan, targeting Chronic Limb Threatening Ischaemia (CLTI).
Biotechnology | 29/10/2025 | By Darshana | 291
DPIIT and Thermo Fisher Scientific Sign MoU to Strengthen India's Biotech Startup Ecosystem
The partnership between DPIIT and Thermo Fisher Scientific to support 500+ biotech startups through advisory, mentorship and nationwide challenge.
Biotechnology | 04/10/2025 | By Dineshwori | 293
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy